Literature DB >> 23897045

Osteoclast formation and differentiation: an overview.

Niroshani Surangika Soysa1, Neil Alles, Kazuhiro Aoki, Keiichi Ohya.   

Abstract

Osteoclasts are multinucleated cells of hematopoietic origin which are unique in their ability to resorb bone. Osteoclasts are generated from myeloid progenitors through a progression that involves the fusion of mononuclear precursor cells. The identification of RANK-RANKL signaling as the main signal regulating osteoclast differentiation was a major breakthrough in the bone biology field. In addition remarkable discoveries have been made to broaden the knowledge of the molecular mechanisms of osteoclast formation and differentiation. Despite the vital requirement of osteoclasts in bone modeling and remodeling, bone-related conditions like osteoporosis, Paget's disease and rheumatoid arthritis where accelerated bone resorption takes place pose a major socioeconomic burden to the society. Hence, a better understanding of the pathways leading to osteoclast differentiation is vital in successfully managing such diseases. This is an attempt to give a birds-eye-view of the players in osteoclast formation and differentiation in a brief and concise manner.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23897045

Source DB:  PubMed          Journal:  J Med Dent Sci        ISSN: 1342-8810


  44 in total

1.  CircRNA_28313/miR-195a/CSF1 axis modulates osteoclast differentiation to affect OVX-induced bone absorption in mice.

Authors:  Xia Chen; Zhengxiao Ouyang; Yi Shen; Bo Liu; Qiang Zhang; Lu Wan; Ziqing Yin; Wei Zhu; Shuai Li; Dan Peng
Journal:  RNA Biol       Date:  2019-06-19       Impact factor: 4.652

Review 2.  Advances in the Fabrication of Scaffold and 3D Printing of Biomimetic Bone Graft.

Authors:  Bharti Bisht; Ashley Hope; Anubhab Mukherjee; Manash K Paul
Journal:  Ann Biomed Eng       Date:  2021-03-05       Impact factor: 3.934

3.  Chemokine ligand 28 (CCL28) negatively regulates trabecular bone mass by suppressing osteoblast and osteoclast activities.

Authors:  Rina Iwamoto; Takumi Takahashi; Kazuto Yoshimi; Yuji Imai; Tsuyoshi Koide; Miroku Hara; Tadashi Ninomiya; Hiroaki Nakamura; Kazutoshi Sayama; Akira Yukita
Journal:  J Bone Miner Metab       Date:  2021-03-15       Impact factor: 2.626

4.  Differential bone remodeling mechanism in hindlimb unloaded rats and hibernating Daurian ground squirrels: a comparison between artificial and natural disuse.

Authors:  Xuli Gao; Siqi Wang; Jie Zhang; Shuyao Wang; Feiyan Bai; Jing Liang; Jiawei Wu; Huiping Wang; Yunfang Gao; Hui Chang
Journal:  J Comp Physiol B       Date:  2021-05-18       Impact factor: 2.200

5.  NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.

Authors:  Yuvaraj Sambandam; Kumaran Sundaram; Takamitsu Saigusa; Sundaravadivel Balasubramanian; Sakamuri V Reddy
Journal:  Bone       Date:  2017-05-12       Impact factor: 4.398

6.  Phospholipase C-related, but catalytically inactive protein (PRIP) up-regulates osteoclast differentiation via calcium-calcineurin-NFATc1 signaling.

Authors:  Ayako Murakami; Miho Matsuda; Yui Harada; Masato Hirata
Journal:  J Biol Chem       Date:  2017-03-24       Impact factor: 5.157

Review 7.  A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.

Authors:  Kin-Hing William Lau; Matilda H-C Sheng
Journal:  Arch Biochem Biophys       Date:  2018-05-17       Impact factor: 4.013

Review 8.  Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years.

Authors:  Ivona Aksentijevich
Journal:  Semin Immunopathol       Date:  2015-04-10       Impact factor: 9.623

9.  A vitronectin-derived peptide reverses ovariectomy-induced bone loss via regulation of osteoblast and osteoclast differentiation.

Authors:  Seung-Ki Min; Hyun Ki Kang; Sung Youn Jung; Da Hyun Jang; Byung-Moo Min
Journal:  Cell Death Differ       Date:  2017-09-22       Impact factor: 15.828

10.  The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway.

Authors:  Hye Jung Ihn; Doohyun Lee; Taeho Lee; Hong-In Shin; Yong Chul Bae; Sang-Hyun Kim; Eui Kyun Park
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.